Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diamicron is a medical technology company specializing in the development of polycrystalline diamond (PCD) for use in orthopedic and spinal implants. The company's proprietary diamond technology provides a highly durable, low-friction bearing surface designed to reduce wear and improve the longevity of joint replacements. Diamicron's primary focus is on cervical disc replacements and hip resurfacing components that leverage the unique biocompatibility and hardness of synthetic diamond. By replacing traditional metal or plastic bearings with PCD, the company aims to eliminate the primary causes of implant failure, such as wear debris and osteolysis. Headquartered in Utah, Diamicron operates as a vertically integrated manufacturer of synthetic diamond components for the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diamicron.